RT @ericdeinmd: L06 #ACR22 ORAL Surveillance Updates! Composite of all ischemic CV events and HF did NOT show difference
Tweet Content
L06 #ACR22 ORAL Surveillance Updates!
Composite of all ischemic CV events and HF did NOT show difference b/w TOFA vs TNFi
But, MACE numerically higher with Tofa w/ h/o ASCVD
Highest CV risk in TOFA 10 mg BID, 2/2 VTE risk
Most important risk is pt's individual risks
@RheumNow https://t.co/jPPX7f5GRE
Show on Archive Page
On
Display in Search Results
On
PDQ
Off